Fractionated evaluation of immunohistochemical hormone receptor expression enhances prognostic prediction in breast cancer patients treated with tamoxifen as adjuvant therapy
about
Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer.Genetic polymorphisms of CYP2D6*10 and the effectiveness of combined tamoxifen citrate and testosterone undecanoate treatment in infertile men with idiopathic oligozoospermiaA novel animal model for locally advanced breast cancer.
P2860
Fractionated evaluation of immunohistochemical hormone receptor expression enhances prognostic prediction in breast cancer patients treated with tamoxifen as adjuvant therapy
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Fractionated evaluation of imm ...... tamoxifen as adjuvant therapy
@ast
Fractionated evaluation of imm ...... tamoxifen as adjuvant therapy
@en
Fractionated evaluation of imm ...... tamoxifen as adjuvant therapy.
@nl
type
label
Fractionated evaluation of imm ...... tamoxifen as adjuvant therapy
@ast
Fractionated evaluation of imm ...... tamoxifen as adjuvant therapy
@en
Fractionated evaluation of imm ...... tamoxifen as adjuvant therapy.
@nl
prefLabel
Fractionated evaluation of imm ...... tamoxifen as adjuvant therapy
@ast
Fractionated evaluation of imm ...... tamoxifen as adjuvant therapy
@en
Fractionated evaluation of imm ...... tamoxifen as adjuvant therapy.
@nl
P2093
P2860
P50
P356
P1476
Fractionated evaluation of imm ...... tamoxifen as adjuvant therapy
@en
P2093
Fu-chang Hu
King-jen Chang
Ling-chu Wu
Yen-shen Lu
P2860
P2888
P356
10.1631/JZUS.B0900295
P577
2010-01-01T00:00:00Z
P6179
1041962620